Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter G Pappas

Showing results (51-60 of 176) with videos related to

Pageof 18
Sort By:
Mycoses|June 15, 2011
Efficacy and safety of micafungin for treatment of serious Candida infections in patients with or without malignant diseaseOliver A Cornely, Francisco M Marty, Flavie Stucker, et al.
Future Microbiology|December 5, 2024
A plain language summary of the STRIVE and ReSTORE studies, which tested if rezafungin is effective and as safe as caspofungin at treating people with candidaemia and invasive candidiasisGeorge R Thompson, Alex Soriano, Oliver A Cornely, et al.
Journal of Clinical Microbiology|January 26, 2018
Efficacy of T2 Magnetic Resonance Assay in Monitoring Candidemia after Initiation of Antifungal Therapy: the Serial Therapeutic and Antifungal Monitoring Protocol (STAMP) TrialEleftherios Mylonakis, Ioannis M Zacharioudakis, Cornelius J Clancy, et al.
Nature Reviews. Disease Primers|May 12, 2018
Invasive candidiasisPeter G Pappas, Michail S Lionakis, Maiken Cavling Arendrup, et al.
Expert Opinion on Drug Safety|February 11, 2011
Accumulated safety data of micafungin in therapy and prophylaxis in fungal diseasesOliver A Cornely, Peter G Pappas, Jo-Anne H Young, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 26, 2019
Reply to Tascini et alRachael A Lee, Todd P McCarty, Bernard C Camins, et al.
International Journal of STD & AIDS|May 17, 2008
Temporary external lumbar drainage for reducing elevated intracranial pressure in HIV-infected patients with cryptococcal meningitisWeerawat Manosuthi, Somnuek Sungkanuparph, Suthat Chottanapund, et al.
Open Forum Infectious Diseases|March 24, 2016
Acute Cryptococcal Immune Reconstitution Inflammatory Syndrome in a Patient on NatalizumabNathan D Gundacker, Stephen J Jordan, Benjamin A Jones, et al.
Diagnostic Microbiology and Infectious Disease|July 4, 2008
Histoplasmosis in HIV-infected patients in a southern regional medical center: poor prognosis in the era of highly active antiretroviral therapyJohn W Baddley, Ishwara R Sankara, J Martin Rodriquez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 2, 2020
Reply to Mafaciolli and PasqualottoPaul E Verweij, Johan Maertens, Sharon C-A Chen, et al.
Pageof 18

Showing results (51-60 of 176) with videos related to

Sort By:
Pageof 18
Mycoses|June 15, 2011
Efficacy and safety of micafungin for treatment of serious Candida infections in patients with or without malignant diseaseOliver A Cornely, Francisco M Marty, Flavie Stucker, et al.
Future Microbiology|December 5, 2024
A plain language summary of the STRIVE and ReSTORE studies, which tested if rezafungin is effective and as safe as caspofungin at treating people with candidaemia and invasive candidiasisGeorge R Thompson, Alex Soriano, Oliver A Cornely, et al.
Journal of Clinical Microbiology|January 26, 2018
Efficacy of T2 Magnetic Resonance Assay in Monitoring Candidemia after Initiation of Antifungal Therapy: the Serial Therapeutic and Antifungal Monitoring Protocol (STAMP) TrialEleftherios Mylonakis, Ioannis M Zacharioudakis, Cornelius J Clancy, et al.
Nature Reviews. Disease Primers|May 12, 2018
Invasive candidiasisPeter G Pappas, Michail S Lionakis, Maiken Cavling Arendrup, et al.
Expert Opinion on Drug Safety|February 11, 2011
Accumulated safety data of micafungin in therapy and prophylaxis in fungal diseasesOliver A Cornely, Peter G Pappas, Jo-Anne H Young, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 26, 2019
Reply to Tascini et alRachael A Lee, Todd P McCarty, Bernard C Camins, et al.
International Journal of STD & AIDS|May 17, 2008
Temporary external lumbar drainage for reducing elevated intracranial pressure in HIV-infected patients with cryptococcal meningitisWeerawat Manosuthi, Somnuek Sungkanuparph, Suthat Chottanapund, et al.
Open Forum Infectious Diseases|March 24, 2016
Acute Cryptococcal Immune Reconstitution Inflammatory Syndrome in a Patient on NatalizumabNathan D Gundacker, Stephen J Jordan, Benjamin A Jones, et al.
Diagnostic Microbiology and Infectious Disease|July 4, 2008
Histoplasmosis in HIV-infected patients in a southern regional medical center: poor prognosis in the era of highly active antiretroviral therapyJohn W Baddley, Ishwara R Sankara, J Martin Rodriquez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 2, 2020
Reply to Mafaciolli and PasqualottoPaul E Verweij, Johan Maertens, Sharon C-A Chen, et al.
Pageof 18